Abstract
Peripheral neuropathy is a common complication of diabetes mellitus1 with an incidence of from 15% to 60%.2,3,4 While estimates vary, as many as 20% of these patients may suffer from considerable painful discomfort.5 Control of blood glucose has been demonstrated to improve motor nerve conduction in diabetic rats and humans,7,8 though this may not improve peripheral nerve function. Treatment of painful diabetic neuropathy has had variable success, and as an attempt to deal with this serious problem, this study was initiated.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
P. J. Dyck, The causes, classification and treatment of peripheral neuropathy, New Engl. J. Med. 307:283 (1982).
P. K. Thomas and S. G. Eliasson, Diabetic neuropathy, in: “Peripheral Neuropathy,” Dyck, Thomas and Lambert, eds., W. B. Saunders, (1972).
W. G. Oakley, D. A. Pyke, R. B. Tattersall, and D. J. Watkins, Longterm diabetes. A clinical study of 92 patients after 40 years, Quarterly J. Med. 196:145 (1974).
A. T. Paz-Guevera, T. H. Hsu, and P. White, Juvenile diabetes after 40 years, Diabetes 24:559 (1975).
J. Pirart, Diabetes mellitus and its degenerative complications, Diabetes Care 1:168 (1978).
A. Winegrad and D. A. Greene, Diabetic polyneuropathy, New Engl. J. Med. 295:1416 (1976).
R. Graf, J. B. Halter, M. A. Pfeifer, E. Harlar, F. Brozovich, and D. Porte, Glycemic control and nerve conduction abnormalities in non-insulin dependent diabetic subjects, Ann. Int. Med. 94:307 (1981).
E. Harlar, R. Graf, J. Halter, F. Brozovich and T. Soine, Diabetic neuropathy: A clinical, laboratory and electro-diagnostic study, Arch. Phys. Med. Rehab. 63:298 (1982).
F. J. Service, J. Daube, P. C. O’Brien, B. R. Zimmerman, C. J. Swanson, M. D. Brennan, and P. J. Dyck, Effect of blood glucose control on peripheral nerve function in diabetic patients, Mayo Clin. Proc. 58:283 (1983).
P. S. Spencer, M. I. Sabris, H. Schaumberg, and C. L. Moore, Does a defect of energy metabolism in the nerve fibers underlie axonal degeneration in polyneuropathies? Ann. Neurol. 5:501 (1979).
A. Winegrad, D. Simmons, and D. B. Martin, Has one diabetic complication been explained? Editorial, New Eng. J. Med. 308:152 (1983).
A. A. F. Sima, Structural and functional characterization of the neuropathy in the spontaneously diabetic BB-Wistar rat, in: “Excerpta Medica,” Y. Goto, A. Horuchi, and K. Kogue, eds., Amsterdam, (1982).
P. J. Dyck, W. B. Sherman, L. M. Hallcher, J. Service, P. O’Brien, L. Grina, P. Palumbo, and C. Swanson, Human diabetic endoneural sorbitol, fructose, and myoinositol related to sural nerve morphometry, Ann. Neurol. 8:590 (1980).
G. Gregerson, B. Bertelsen, H. Harbo, E. Larsen, J. Rud Andersen, A. Helles, M. Schmiegelow, J. Just Christensen, Oral supplementation of myoinositol: Effects on peripheral nerve functions in human diabetics and on concentration in plasma, erythrocytes, urine and muscle tissue in human diabetics and normals, Acta Neurol. Scand. 67:164 (1983).
R. G. Judzewitsch, J. B. Jaspan, K. S. Polonsky, C. R. Weinberg, J. B. Halter, E. Halar, M. A. Pfeifer, C. Vukadinovic, L. Bernstein, M. Schneider, K.-Y. Liang, K. H. Gabbay, A. H. Rubenstein, D. Porte, Jr., Aldose reductase inhibition improves nerve conduction velocity in diabetic patients, New Engl. J. Med. 308:119 (1983).
M. Brown, J. R. Martin, A. K. Asbury, Painful diabetic neuropathy, Arch. Neurol. 33:164 (1976).
F. Roisen, H. Bartfeld, R. Nagele, and G. Yorke, Ganglioside stimulation of axonal sprouting in vitro, Science 214:577 (1981).
A. Gorio, G. Carmignoto, L. Facci, M. Finesso, Motor nerve sprouting induced by ganglioside treatment. Possible implications for gangliosides on neuronal growth, Brain Res. 197:236 (1980).
S. Ando, N.-C. Chang, and R. K. Yu, High performance thin-layer chromatography and densitometric determination of brain ganglioside compositions of several species, Anal. Biochem. 89:437 (1978).
P. H. Fishman, J. Moss and V. C. Manganiello, Synthesis and uptake of gangliosides by choleragen responsive human fibroblasts, Biochem. 16:1871 (1977).
P. H. Fishman, R. O. Brady, and S. A. Aronson, A comparison of membrane glycoconjugates from mouse cells transformed by murine and primate RNA sarcoma virus, Biochem. 15:201 (1976).
F. Roisen, H. Bartfeld, and M. Rapport, Ganglioside mediation of in vitro neuronal maturation, in: “Gangliosides in Neurological and Neuromuscular Function, Development and Repair,” M. M. Rapport and A. Gorio, eds., Raven Press, New York, (1981).
M. Kalra and J. DePalma, Ganglioside induced acceleration of axonal transport following nerve crush injury in the rat, Neuroscience Letters 34:1 (1982).
G. Tettamanti, Ganglioside and receptor activity (Abstract), Muscle and Nerve Nov. (1978).
G. Pozza, V. Saibene, G. Comi, and N. Canal, The effect of ganglioside administration in human diabetic peripheral neuropathy, in: “Gangliosides in Neurological and Neuromuscular Function, Development and Repair,” M. M. Rapport and A. Gorio, eds., Raven Press, New York (1981).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Naarden, A., Davidson, J., Harris, L., Moore, J., DeFelice, S. (1984). Treatment of Painful Diabetic Polyneuropathy with Mixed Gangliosides. In: Ledeen, R.W., Yu, R.K., Rapport, M.M., Suzuki, K. (eds) Ganglioside Structure, Function, and Biomedical Potential. Advances in Experimental Medicine and Biology, vol 174. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1200-0_49
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1200-0_49
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1202-4
Online ISBN: 978-1-4684-1200-0
eBook Packages: Springer Book Archive